Using mobile units to provide medication for opioid use disorder in New York.
Official title: Implementation of Mobile Medication Units for Patients with Opioid Use Disorder in New York.
Funded at Johns Hopkins University · NIH-10931624 · Data updated 2026-11-12
This study is looking at how mobile units that provide methadone can help people with opioid use disorder in New York get the treatment they need more easily, especially if they have trouble reaching regular clinics, and it will share what works and what doesn’t to help similar programs in other places.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | September 30, 2023 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $204,688 |
| NIH project number | 5R21DA058117-02 |
| Project ID | NIH-10931624 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with opioid use disorder who have difficulty accessing traditional treatment facilities.
✕Less likely to help
Patients who are not diagnosed with opioid use disorder or those who have access to traditional treatment programs may not benefit from this research.
What this research studies
This research investigates the implementation of mobile medication units that dispense methadone for patients with opioid use disorder (OUD) in New York. By utilizing mobile units, the project aims to improve access to treatment for individuals who face barriers in reaching traditional opioid treatment programs. The study will explore the challenges and successes of launching these mobile units, which could also offer additional services like counseling. The findings will help inform similar initiatives in other states during the ongoing national overdose crisis.
Why it matters
Potential benefit: If successful, this research could significantly improve access to life-saving medication and support services for individuals struggling with opioid use disorder.
How similar studies have gone: Other research has shown promise in expanding access to treatment through mobile units, indicating that this approach could be effective.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Researchers
- Principal investigator: Saloner, Brendan K — Johns Hopkins University
- Study coordinator: Saloner, Brendan K
Related research
Other NIH-funded projects on the same topics.
-
Systems analysis to improve opioid use disorder care after jail release (SAIA-MOUD)
A program to help people with opioid use disorder get better, faster, and safer care after they leave jail.
-
Precise epigenetic drugs for opioid addiction
A tiny, targeted drug approach is being developed to help people with opioid use disorder by rewriting the epigenetic signals in the brain to reduce cravings and relapse risk.
-
Increasing Access to Medications for Opioid Use Disorder for Unhoused Montanans
This project helps unhoused people in Montana get life-saving medicines for opioid use disorder through clinics connected to syringe service programs, a nurse-led MOUD model, and peer support.
-
Optimizing long-acting PrEP and opioid treatment for people in jails and prisons
This project tests a real-world approach to using long-acting PrEP and buprenorphine for HIV prevention and opioid treatment among incarcerated individuals and after release.
-
Scaling up medications for opioid use disorder in residential treatment programs
This grant studies how to help residential treatment programs provide medications for opioid use disorder to reduce overdoses after discharge, focusing on real-world settings and policies.
-
Increasing Capacity at a Native Community Clinic to Improve Opioid Care for urban AI/AN
This grant helps a Native American health clinic build its research capacity to better serve urban American Indian and Alaska Native people dealing with opioid use disorder and related health issues.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.